PTPI — Petros Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00- $3.77m
- $7.12m
- $5.82m
- 46
- 50
- 27
- 36
Annual income statement for Petros Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 15.6 | 9.56 | 7.81 | 5.99 | 5.82 |
| Cost of Revenue | |||||
| Gross Profit | 8.15 | 5.51 | 6.21 | 3.7 | 4.19 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 34.9 | 26.8 | 25.9 | 25.9 | 19.4 |
| Operating Profit | -19.3 | -17.3 | -18 | -19.9 | -13.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -33.2 | -22 | -8.99 | -20 | -8.16 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -32.5 | -20.6 | -8.99 | -20 | -8.16 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -32.5 | -20.6 | -8.99 | -20 | -8.16 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -32.5 | -20.6 | -8.99 | -20 | -13.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -31.9 | -21.2 | -8.25 | -7.71 | -6.35 |
| Dividends per Share |